HHealth Read More A µ-opioid receptor superagonist analgesic with minimal adverse effectsApril 2, 2026 Binding screen These experiments were performed by a commercial vendor (Eurofins) under contract with the National Institutes of…
BBusiness Read More JPM 2026: Novo Nordisk’s Jacob Peterson on the Future of Obesity TherapeuticsJanuary 23, 2026 Novo Nordisk is doubling down on obesity and diabetes. Speaking with Inside Precision Medicine at the 2026 J.P.…